Uncategorized

OcuTerra Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

by Business Wire • 2024/01/04 • 0 Comments

BOSTON--(BUSINESS WIRE)--OcuTerra Therapeutics announces President and CEO Kerrie Brady will present at the J.P. Morgan Healthcare Conference in San Francisco on January 11.

← Aldeyra Therapeutics Provides Clinical and Regulatory Update and Announces Advancement of RASP Platform in Systemic and Retinal Inflammatory Diseases

Harrow partnerships to support Vevye launch →

Post navigation